The latest news stories from GMDN Agency.
MHRA and ANVISA representatives have joined the Authorities Strategic Advisory Group (ASAG) committee, which represents medical device regulators that use the GMDN.
21 Mar 2023
The GMDN Agency delivered three virtual strategy workshops this month (March 2023) as part of our Corporate Strategy 2022 – 2026 implementation.
14 Mar 2023
The GMDN has been listening to the views of nomenclature users to help shape the future of medical device identification.
14 Mar 2023
The GMDN Agency are pleased to welcome a new team member to help us communicate our strategy and engage with all of our stakeholders.
14 Mar 2023
On 26th January 2023 the GMDN was approved as a fundamental standard supporting the identification of medical devices for the NHS
10 Feb 2023
The WHO Essential Diagnostic List (EDL) is a selection of reference IVD tests that can be used as a basis for a national list of essential in vitro diagnostic tests.
07 Feb 2023
Please register by emailing communications@gmdnagency.org to receive joining details
07 Feb 2023 · Feature
More details here...
16 Jan 2023